Evidence map›Paper›PMID 24355521›Full record

ArticleBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2014

Symptom distress predicts long-term health and well-being in allogeneic stem cell transplantation survivors.

Margaret F Bevans, Sandra A Mitchell, John A Barrett, Michael R Bishop, Richard Childs, Daniel Fowler, Michael Krumlauf, Patricia Prince, Nonniekaye Shelburne, Leslie Wehrlen and 1 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00128960 (Prospective Assessment of Functional Status, Psychosocial Adjustment, Health Related Quality of Life and the Symptom Experience in Patients Treated With Allogeneic Hematopoietic Stem Cell Transplantation), which is not on this map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00128960 completednot on this map

Prospective Assessment of Functional Status, Psychosocial Adjustment, Health Related Quality of Life and the Symptom Experience in Patients Treated With Allogeneic Hematopoietic Stem Cell Transplantation

TypeobservationalSponsorNational Institutes of Health Clinical Center (CC)Ran2005Enrolled173ConditionsLong Term Psychological Affects on HSCT
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 47 citations in OpenAlex.

  1. Effects of expressive helping writing during stem cell transplant: Randomized controlled trial.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2025
    Trial
  2. Trial
  3. A mindfulness-based program for improving quality of life among hematopoietic stem cell transplantation survivors: feasibility and preliminary findings.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2015
    Trial
  4. Fatigue and quality of life in the early phase after allogeneic hematopoietic stem cell transplantation: dynamics and the impact of graft-versus-host disease.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  5. Patients' symptoms and challenges during the first year after allogeneic haematopoietic cell transplantation-patients' own expressions.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  6. Symptom distress evolution over the first year after allogeneic stem cell transplantation - a prospective observational sub-study of the SMILe project.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Observational
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Fatigue predicts impaired social adjustment in survivors of allogeneic hematopoietic cell transplantation (HCT).Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019
    Article
  13. "Improving to where?": treatment-related health risks and perceptions of the future among adolescents and young adults after hematopoietic cell transplantation.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019
    Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Everyday life following hematopoietic stem cell transplantation: decline in physical symptoms within the first month and change-related predictors.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2018
    Article
  19. Article
  20. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Margaret F BevansNursing Department, National Institutes of Health Clinical Center, Bethesda, Maryland. Electronic address: mbevans@cc.nih.gov.
Sandra A MitchellApplied Research Program, Outcomes Research Branch, National Cancer Institute, NIH, Rockville, Maryland; Experimental Transplantation and Immunology Branch, National Cancer Institute, NIH, Bethesda, Maryland.
John A BarrettHematology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland.
Michael R BishopSection of Hematology/Oncology, University of Chicago, Chicago, Illinois.
Richard ChildsHematology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland.
Daniel FowlerExperimental Transplantation and Immunology Branch, National Cancer Institute, NIH, Bethesda, Maryland.
Michael KrumlaufNursing Department, National Institutes of Health Clinical Center, Bethesda, Maryland.
Patricia PrinceNursing Department, National Institutes of Health Clinical Center, Bethesda, Maryland; Social Work Department, National Institutes of Health Clinical Center, Bethesda, Maryland.
Nonniekaye ShelburneApplied Research Program, Outcomes Research Branch, National Cancer Institute, NIH, Rockville, Maryland; Division of Cancer Control and Population Sciences, National Cancer Institute, NIH, Rockville, Maryland.
Leslie WehrlenNursing Department, National Institutes of Health Clinical Center, Bethesda, Maryland.
Li YangNursing Department, National Institutes of Health Clinical Center, Bethesda, Maryland.
National Institutes of Health Clinical Center · USApplied Research (United States) · USNational Heart Lung and Blood Institute · USNational Cancer Institute · USUniversity of Chicago · US

Funding

Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation TherapyZIASC010288 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI FOWLER, DANIEL · 2009 to 2017
$6.3M
Long Term Quality of Life Outcomes in Patients Treated with Allogeneic HSCTZ01CL001144 · CLC · CLINICAL CENTER · PI BEVANS, MARGARET F · 2005 to 2008
$98k
Long Term Quality of Life Outcomes in Patients Treated with Allogeneic HSCTZIACL001144 · CLC · CLINICAL CENTER · PI BEVANS, MARGARET · 2009 to 2018
$0k
Intramural NIH HHS Z01 CL001144
6 · The paper itself

Abstract

The number of survivors after allogeneic hematopoietic stem cell transplantation (HSCT) continues to increase, yet their survivorship experience has not been fully characterized. This study examines the health status and health-related quality of life (HRQL) of HSCT survivors. The aims of the study were to: (1) explore the baseline and change over time in these health outcomes, and (2) characterize subgroups experiencing adverse outcomes. In this longitudinal study, adults who survived >3 years from date of allogeneic HSCT completed a series of patient-reported outcome measures annually, including measures of health status, HRQL, and symptoms. Data were analyzed using hierarchical linear modeling. Subjects (N = 171) were on average 44 (±13.5) years of age and primarily male (62.6%); 40% were Hispanic. Mean scores for physical and mental health and HRQL were preserved relative to population norms. Hierarchical linear modeling revealed no significant change in the mean trajectories of these outcomes, although significant between-individual variability was observed. When controlling for demographic and clinical factors, physical symptom distress negatively affected all outcomes. The impact of symptom distress on physical health varied based on time since HSCT; impairment in physical health was greatest in survivors experiencing high symptom distress and who were within the first decade post transplantation. Extended treatment with systemic immunosuppressive therapy also predicted inferior physical health. These findings suggest that patient-centered outcomes are preserved relative to normative values and are generally stable after allogeneic HSCT, although survivors with persistent symptoms and those receiving systemic immunosuppression experience impairments in health status and HRQL.

Indexed as

Hematopoietic Stem Cell TransplantationAdultFemaleHealth StatusHematologic NeoplasmsHumansImmunosuppressive AgentsLongitudinal StudiesMaleMental HealthMiddle AgedPatient Outcome AssessmentQuality of LifeStress, PsychologicalSurvivorsTransplantation, HomologousImmunosuppressive AgentsAllogeneic hematopoietic stem cell transplantationFatigueFunctional statusHealth-related quality of lifeSymptom experience

Identifiers

PMID24355521
PMCPMC3962950
OpenAlexW2123426031

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.